Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic Advair: Finally Approved, A Long Time Coming

Clock numbers in close up

Related Content

Mylan Sees Generic Advair Marathon Nearing FDA Finish Line

Nov 06 2018

Mylan To Explore Strategic Options, Claiming Investors Have Failed To Appreciate The Value

Aug 08 2018

Related Companies

GSK plc

Viatris Inc.

Novartis AG

Hikma Pharmaceuticals plc

ViiV Healthcare

Teva Pharmaceutical Industries Ltd.

Additional Topics

Approvals Generic Drugs Pricing Strategies Companies Commercial Policy BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window